Ausdal Financial Partners’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.12M | Buy |
5,301
+2,128
| +67% | +$458K | 0.05% | 350 |
|
|
2025
Q4 | $652K | Sell |
3,173
-121
| -4% | -$22.8K | 0.03% | 459 |
|
|
2025
Q3 | $517K | Sell |
3,294
-959
| -23% | -$148K | 0.03% | 549 |
|
|
2025
Q2 | $715K | Sell |
4,253
-627
| -13% | -$93.1K | 0.05% | 331 |
|
|
2025
Q1 | $672K | Sell |
4,880
-42
| -0.9% | -$5.35K | 0.05% | 318 |
|
|
2024
Q4 | $582K | Sell |
4,922
-45
| -0.9% | -$5.25K | 0.05% | 321 |
|
|
2024
Q3 | $549K | Sell |
4,967
-3,129
| -39% | -$327K | 0.06% | 287 |
|
|
2024
Q2 | $796K | Sell |
8,096
-352
| -4% | -$35.9K | 0.09% | 209 |
|
|
2024
Q1 | $945K | Sell |
8,448
-944
| -10% | -$102K | 0.11% | 180 |
|
|
2023
Q4 | $947K | Sell |
9,392
-375
| -4% | -$37.2K | 0.12% | 166 |
|
|
2023
Q3 | $848K | Buy |
9,767
+380
| +4% | +$34.4K | 0.12% | 169 |
|
|
2023
Q2 | $888K | Sell |
9,387
-1,997
| -18% | -$169K | 0.12% | 173 |
|
|
2023
Q1 | $859K | Buy |
11,384
+1
| +0% | +$75 | 0.12% | 180 |
|
|
2022
Q4 | $875K | Sell |
11,383
-325
| -3% | -$24.7K | 0.13% | 173 |
|
|
2022
Q3 | $781K | Sell |
11,708
-1,001
| -8% | -$63.5K | 0.12% | 187 |
|
|
2022
Q2 | $664K | Hold |
12,709
| – | – | 0.1% | 224 |
|
|
2022
Q1 | $721K | Buy |
12,709
+1
| +0% | +$54 | 0.1% | 216 |
|
|
2021
Q4 | $654K | Buy |
12,708
+40
| +0.3% | +$1.96K | 0.09% | 239 |
|
|
2021
Q3 | $627K | Buy |
12,668
+50
| +0.4% | +$2.71K | 0.09% | 240 |
|
|
2021
Q2 | $720K | Buy |
12,618
+60
| +0.5% | +$3.51K | 0.11% | 205 |
|
|
2021
Q1 | $763K | Sell |
12,558
-1,000
| -7% | -$55.2K | 0.13% | 186 |
|
|
2020
Q4 | $726K | Buy |
13,558
+1,000
| +8% | +$51.9K | 0.14% | 170 |
|
|
2020
Q3 | $590K | Hold |
12,558
| – | – | 0.14% | 165 |
|
|
2020
Q2 | $655K | Sell |
12,558
-1,186
| -9% | -$61.1K | 0.22% | 118 |
|
|
2020
Q1 | $697K | Sell |
13,744
-50
| -0.4% | -$2.6K | 0.25% | 107 |
|
|
2019
Q4 | $741K | Sell |
13,794
-1,350
| -9% | -$69.7K | 0.22% | 121 |
|
|
2019
Q3 | $715K | Hold |
15,144
| – | – | 0.25% | 105 |
|
|
2019
Q2 | $703K | Hold |
15,144
| – | – | 0.27% | 98 |
|
|
2019
Q1 | $729K | Hold |
15,144
| – | – | 0.3% | 84 |
|
|
2018
Q4 | $675K | Sell |
15,144
-45
| -0.3% | -$2.35K | 0.33% | 78 |
|
|
2018
Q3 | $820K | Buy |
15,189
+200
| +1% | +$10.2K | 0.23% | 131 |
|
|
2018
Q2 | $732K | Sell |
14,989
-1
| -0% | -$57 | 0.23% | 136 |
|
|
2018
Q1 | $940K | Sell |
14,990
-225
| -1% | -$15.4K | 0.33% | 90 |
|
|
2017
Q4 | $932K | Sell |
15,215
-1,735
| -10% | -$107K | 0.33% | 90 |
|
|
2017
Q3 | $1.13M | Buy |
16,950
+150
| +0.9% | +$10.6K | 0.45% | 59 |
|
|
2017
Q2 | $1.31M | Buy |
+16,800
| New | +$1.27M | 0.56% | 43 |
|
|
2016
Q1 | – | Sell |
-449
| Closed | -$40K | – | 322 |
|
|
2015
Q4 | $40K | Buy |
+449
| New | +$38.1K | 0.02% | 520 |
|
Other funds holding CAH
VCM
VPM
Ausdal Financial Partners's CAH Position: Q1 2026 in Review
Ausdal Financial Partners increased its Cardinal Health (CAH) stake by 67% in Q1 2026, buying an estimated $458K and bringing the position to 5,301 shares worth $1.12M. The position accounts for 0.05% of the portfolio, ranked #350.
Ausdal Financial Partners first reported a position in CAH in Q4 2015 and has held it in 37 quarters since. The position peaked at $1.31M in Q2 2017. 1,426 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Ausdal Financial Partners held 5,301 shares of Cardinal Health worth $1.12M as of Q1 2026.
- Ausdal Financial Partners bought 2,128 Cardinal Health shares in Q1 2026, an estimated $458K.
- Cardinal Health made up 0.05% of Ausdal Financial Partners's portfolio in Q1 2026, its #350 holding.
- Ausdal Financial Partners first reported a position in Cardinal Health in Q4 2015 and has held it in 37 quarters since.
- Ausdal Financial Partners's Cardinal Health position peaked at $1.31M in Q2 2017.
- 1,426 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Ausdal Financial Partners's 13F filing for Q1 2026, filed 12 May 2026.